[Federal Register Volume 79, Number 116 (Tuesday, June 17, 2014)]
[Notices]
[Pages 34551-34552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-14145]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: ALKERMES 
GAINESVILLE LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.34(a) on or before July 17, 2014. Such persons may also file a 
written request for a hearing on the application pursuant to 21 CFR 
1301.43 on or before July 17, 2014.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, and

[[Page 34552]]

dispensers of controlled substances (other than final orders in 
connection with suspension, denial, or revocation of registration) has 
been redelegated to the Deputy Assistant Administrator of the DEA 
Office of Diversion Control (``Deputy Assistant Administrator'') 
pursuant to sec. 7(g) of 28 CFR pt. 0, subpt. R, App.
    In accordance with 21 CFR 1301.34(a), this is notice that on May 8, 
2014, Alkermes Gainesville LLC, 1300 Gould Drive, Gainesville, Georgia 
30504, applied to be registered as an importer of Noroxymorphone 
(9668), a basic class of controlled substance listed in schedule II.
    The company plans to import the above listed controlled substance 
for analytical research and testing.
    The import of the above listed basic class of controlled substance 
would be granted only for analytical testing and clinical testing. This 
authorization does not extend to the import of a finished Food and Drug 
Administration approved or non-approved dosage form for commercial 
distribution in the United States.

    Dated: June 10, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-14145 Filed 6-16-14; 8:45 am]
BILLING CODE 4410-09-P